v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2024 |
Sep. 30, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
|
| Revenues: | ||||
| Revenues | $ 173,632 | $ 178,595 | $ 529,504 | $ 681,591 |
| Costs and expenses: | ||||
| Selling, general and administrative | 98,203 | 72,240 | 237,191 | 227,676 |
| Research and development | 28,770 | 19,435 | 74,789 | 70,199 |
| Contingent consideration | 0 | (1,125) | 0 | (1,023) |
| Amortization of intangible assets | 20,433 | 21,534 | 62,290 | 64,543 |
| Gain on sale of assets | (121,493) | 0 | (121,493) | 0 |
| Total costs and expenses | 159,416 | 243,002 | 648,430 | 769,566 |
| Operating income (loss) | 14,216 | (64,407) | (118,926) | (87,975) |
| Other income and (expense), net: | ||||
| Interest income | 2,928 | 970 | 4,132 | 3,077 |
| Interest expense | (17,359) | (3,384) | (33,225) | (10,053) |
| Fair value changes of derivative instruments, net | (1) | 88 | (26,161) | (829) |
| Other income (expense), net | 48,636 | (11,645) | 128,834 | (16,045) |
| Other income (expense), net | 34,204 | (13,971) | 73,580 | (23,850) |
| Income (loss) before income taxes and investment losses | 48,420 | (78,378) | (45,346) | (111,825) |
| Income tax provision | (23,527) | (6,075) | (21,898) | (10,456) |
| Net income (loss) before investment losses | 24,893 | (84,453) | (67,244) | (122,281) |
| Loss from investments in investees | (3) | (20) | (7) | (99) |
| Net income (loss) | $ 24,890 | $ (84,473) | $ (67,251) | $ (122,380) |
| Income (loss) per share: | ||||
| Income (loss) per share, basic (in dollars per share) | $ 0.04 | $ (0.11) | $ (0.1) | $ (0.16) |
| Income (loss) per share, diluted (in dollars per share) | $ 0.03 | $ (0.11) | $ (0.1) | $ (0.16) |
| Weighted average common shares outstanding, basic (in shares) | 694,622,466 | 751,525,007 | 699,675,944 | 751,716,692 |
| Weighted average common shares outstanding, diluted (in shares) | 998,363,636 | 751,525,007 | 699,675,944 | 751,716,692 |
| Service [Member] | ||||
| Revenues: | ||||
| Revenues | $ 121,271 | $ 131,679 | $ 377,557 | $ 391,100 |
| Costs and expenses: | ||||
| Cost of Goods and Services Sold | 108,847 | 106,375 | 325,798 | 333,460 |
| Product [Member] | ||||
| Revenues: | ||||
| Revenues | 39,143 | 40,670 | 117,675 | 124,553 |
| Costs and expenses: | ||||
| Cost of Goods and Services Sold | 24,656 | 24,543 | 69,855 | 74,711 |
| Transfer of Intellectual Property and Other [Member] | ||||
| Revenues: | ||||
| Revenues | $ 13,218 | $ 6,246 | $ 34,272 | $ 165,938 |
| X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations, after deduction of income tax expense (benefit), but before income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|